Financial Reports
Related Searches:
Filter by:
346 - 360 of 676 results
January 27, 2010
In the quarter, Pharmaceutical sales were up 21% to $7.8 billion.
Read More »
January 27, 2010
Product sales increased 30% to a record $1.8 billion in 4Q09.
Read More »
January 26, 2010
Worldwide Pharmaceutical sales were $22.5 billion for the year (-8%), while Worldwide Medical Devices and Diagnostics sales were $23.6 billion for year (+2%).
Read More »
January 26, 2010
Product sales were up 2% to $3.7 billion in 4Q09.
Read More »
January 26, 2010
Consolidated service revenue for quarter was $221.6 million in Clinical Research Services (CRS), $29.7 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $33.4 million in Perceptive Informatics, Inc.
Read More »
December 18, 2009
Full-year revenues down 9% between commercial and development service groups.
Read More »
November 5, 2009
Early Stage revenue was $10.8 million (-4%) and YTD was $27.2 million (+7%).
Read More »
November 5, 2009
CRO business revenues were $36.9 million in the quarter (-28%).
Read More »
November 3, 2009
Product sales in the quarter were down 1% to $28.6 million.
Read More »
November 3, 2009
Pharmaceutical Systems segment sales for the third quarter of were $198.1 million (+4%).
Read More »
October 30, 2009
Pharmaceutical sales were up 6% to $9.3 billion in the quarter and YTD sales rose 4% to $28.5 billion.
Read More »
October 30, 2009
Eli Lilly and Co. has opened its new Biotechnology Center in San Diego, as part of its strategy to develop more biopharmaceuticals.
Read More »
October 29, 2009
Sales of Influenza A (H1N1) vaccine totaled $152 million in the quarter. Nexium sales were down 5% to $1.2 billion.
Read More »
October 29, 2009
In the quarter, Diabetes care sales were $1.8 billion (+12%). Biopharmaceutical sales were $636.3 (+10%).
Read More »
346 - 360 of 676 results
